Home > Financial Ratios > BLISS GVS PHARMA

BLISS GVS PHARMA
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for BLISS GVS PHARMA
Please provide your vote to see the results

BLISS GVS PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 5.865.464.847.726.51

What is the latest EV/Core EBITDA ratio of BLISS GVS PHARMA ?

The latest EV/Core EBITDA ratio of BLISS GVS PHARMA is 5.86 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20245.86
Mar20235.46
Mar20224.84
Mar20217.72
Mar20206.51

How is EV/Core EBITDA of BLISS GVS PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2024 5.86
7.33
Mar2023 5.46
12.81
Mar2022 4.84
-37.31
Mar2021 7.72
18.59
Mar2020 6.51 -

Other Financial Ratios of BLISS GVS PHARMA


Compare EV/Core EBITDA ratio of peers of BLISS GVS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BLISS GVS PHARMA ₹1,266.4 Cr 0.1% -5.1% -0.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,188.0 Cr -1.5% 4.6% 3% Stock Analytics
DIVIS LABORATORIES ₹143,074.0 Cr -4.8% -3.2% 40.7% Stock Analytics
CIPLA ₹115,768.0 Cr -1.3% -1.9% -5.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹109,809.0 Cr 1.1% 6.1% 27.1% Stock Analytics
DR REDDYS LABORATORIES ₹92,503.5 Cr -3.6% -2.7% -11.4% Stock Analytics


BLISS GVS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
BLISS GVS PHARMA

0.1%

-5.1%

-0.9%

SENSEX

-2.4%

0.7%

0.5%


You may also like the below Video Courses